Sign up to save your podcasts
Or
Share E123: Upadacitinib for Giant Cell Arteritis: SELECT-GCA
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
E123: Upadacitinib for Giant Cell Arteritis: SELECT-GCA
Podcast this week about the recently published SELECT-GCA study, which evaluated the use of the janus kinase inhibitor upadacitinib (Rinvoq) for patients with new and relapsing GCA. Successful trial and an interesting topic. Paper itself here: https://www.nejm.org/doi/full/10.1056/NEJMoa2413449
View all episodes
By Michael Putman
4.9
111111 ratings
Podcast this week about the recently published SELECT-GCA study, which evaluated the use of the janus kinase inhibitor upadacitinib (Rinvoq) for patients with new and relapsing GCA. Successful trial and an interesting topic. Paper itself here: https://www.nejm.org/doi/full/10.1056/NEJMoa2413449
More shows like The Evidence Based Rheumatology Podcast
View all
JAMA Clinical Reviews
493 Listeners
Rheumnow Podcast
124 Listeners
The Curbsiders Internal Medicine Podcast
3,332 Listeners
Core IM | Internal Medicine Podcast
1,095 Listeners
Healio Rheuminations
120 Listeners
The Clinical Problem Solvers
519 Listeners
ACR on Air
69 Listeners
Around the Rheum
4 Listeners
Rheumatology For The Royal College
172 Listeners
RheumMadness Rheumatology Podcast
11 Listeners
The Lancet Rheumatology in conversation with
0 Listeners
Talking Rheumatology Research
1 Listeners
Talking Rheumatology
0 Listeners
Talking Rheumatology Spotlight
5 Listeners
ACR Journals On Air
17 Listeners